phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with veratridine in 1 studies
Studies (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Trials (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Studies (veratridine) | Trials (veratridine) | Recent Studies (post-2010) (veratridine) |
---|---|---|---|---|---|
276 | 0 | 55 | 1,755 | 0 | 86 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castes, E; Devillers, JP; Labrouche, SA; Simonnet, G | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and veratridine
Article | Year |
---|---|
Release of neuropeptide FF, an anti-opioid peptide, in rat spinal cord slices is voltage- and Ca(2+)-sensitive: possible involvement of P-type Ca2+ channels.
Topics: Animals; Calcium; Calcium Channels; Electrophysiology; Endorphins; In Vitro Techniques; Male; Oligopeptides; Ouabain; Perfusion; Potassium; Radioligand Assay; Rats; Rats, Wistar; Spinal Cord; Veratridine | 1995 |